Industry's Giant Leap Into Cellular Therapy: Catalyzing Chimeric Antigen Receptor T Cell (CAR-T) Immunotherapy.
Ittershagen S, Ericson S, Eldjerou L, Shojaee A, Bleickardt E, Patel M, Taran T, Anak O, Hall C, Leung M, Roccoberton D, Salmon F, Fuchs M, Romanov V, Lebwohl D.
Ittershagen S, et al. Among authors: ericson s.
Curr Hematol Malig Rep. 2019 Feb;14(1):47-55. doi: 10.1007/s11899-019-0498-6.
Curr Hematol Malig Rep. 2019.
PMID: 30666506
Review.